Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
about
Real-Time PCR: Revolutionizing Detection and Expression Analysis of GenesVaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.Immunological properties of gold nanoparticlesApproaches to enhance the efficacy of DNA vaccines.Particle-mediated DNA vaccine delivery to the skin.General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.Optimization and delivery of plasmid DNA for vaccination.Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K.The PEN1 syntaxin defines a novel cellular compartment upon fungal attack and is required for the timely assembly of papillae.Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.).Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells.DNA ministrings: highly safe and effective gene delivery vectors.Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.Identification of differentially expressed genes in individual bovine preimplantation embryos produced by nuclear transfer: improper reprogramming of genes required for development.Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8.
P2860
Q24653633-17AA23C8-328A-4747-8D10-CA60645581AAQ33575384-BA6D5647-2C6A-4171-9577-A7FDE084202BQ33578950-C15C8DD3-A107-4DA0-9F19-F5E21F48E536Q35743279-F1762007-0D28-4041-9ED8-026AF40897BFQ35790864-944AE045-FA8D-411C-8872-91DD6758749CQ35947735-9F0D125D-1F95-404B-B362-3ED52CE078E3Q36690285-EBE1D734-3F53-4BE9-94DE-67FE5A993EF2Q37001633-A8C2E7A2-D5FC-4AC5-A1E4-34B4F2BEDFF0Q37182874-B5EBA065-B60C-49B6-9CF1-9D7446E50092Q37595500-2748B4F5-0AB0-4547-AB87-05A3E14DBB75Q39606955-CE3AC8C7-BDC5-468F-9C6A-7FC5C1B85CB1Q39682677-155949BB-7C29-4B8F-B830-B67707396961Q40011716-7B1CD1AE-5E5E-4AA4-8636-2AD060157BCDQ41120661-3A1F8A2E-58DB-4B1A-B67A-89808F4BBAB1Q42006658-69997A14-021B-467D-AA71-D65F93DE25ACQ42948028-AC68B845-F775-4C4A-847A-FA021C54EFF8Q45106152-60940054-7AF2-4093-B785-DC24436B9190Q45644133-1F25A841-A4DE-4229-A161-818A6F13438D
P2860
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@ast
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@en
type
label
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@ast
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@en
prefLabel
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@ast
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@en
P2093
P2860
P1433
P1476
Immunization of cats against f ...... IL-12), IL-16, or a CpG motif.
@en
P2093
C Junghans
C M Leutenegger
C N Mislin
F S Boretti
P2860
P304
10447-10457
P356
10.1128/JVI.74.22.10447-10457.2000
P577
2000-11-01T00:00:00Z